This is a working overview of REV-ERB, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-07-01. Anything still debated is marked as such rather than presented as settled.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine in major jurisdictions | Sold as a research chemical; legal status varies |
| Anti-doping status | Prohibited by the World Anti-Doping Agency | Listed under non-approved substances or related category |
| Typical analytical method | LC-MS/MS | Used for detection and confirmation in biological samples |
| Storage temperature | −20 °C or lower for solid | Desiccated and protected from light |
| Common solution solvents | DMSO; ethanol | Aqueous solubility is limited |
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Providing a plane of separation, or disconnection, between solid tissues so that movement can occur with minimum bending of solid components. If this separation is lost, as in a 'frozen shoulder', the joint cannot move. Providing a packing that can change shape in whatever way is needed to allow the bearing surfaces to move on each other. Controlling the volume of fluid in the cavity so that it is just enough to allow the solid components to move over each other freely. This volume is normally so small that the joint is under slight suction.
Bioelectrical impedance analysis (BIA) Computed tomography (CT scans) Dual-energy X-ray absorptiometry (DEXA) Magnetic resonance imaging (MRI) However, these methods are not widely used because they can be expensive and difficult to access.
Whereas the Principal Allied Powers have also agreed that the Mandatory should be responsible for putting into effect the declaration originally made on November 2nd, 1917, by the Government of His Britannic Majesty, and adopted by the said Powers, in favor of the establishment in Palestine of a national home for the Jewish people, it being clearly understood that nothing should be done which might prejudice the civil and religious rights of existing non-Jewish communities in Palestine, or the rights and political status enjoyed by Jews in any other country.... A statement on "British Policy in Palestine," issued on 3 June 1922 by the Colonial Office, placed a restrictive construction upon the Balfour Declaration. The statement excluded "the disappearance or subordination of the Arabic population, language or customs in Palestine" or "the imposition of Jewish nationality upon the inhabitants of Palestine as a whole", and made it clear that in the eyes of the mandatory Power, the Jewish National Home was to be founded in Palestine and not that Palestine as a whole was to be converted into a Jewish National Home. The Committee noted that the construction, which restricted considerably the scope of the National Home, was made prior to the confirmation of the Mandate by the Council of the League of Nations and was formally accepted at the time by the Executive of the Zionist Organization. The Partition Resolution of the UN General Assembly died at birth when rejected by the Arabs. The UNGA has only the power to recommend.
Sources: en.wikipedia.org
An immediate ceasefire. The withdrawal of MNLA and HCUA forces to designated cantonment sites, primarily around Kidal. The deployment of the Malian army to Kidal to secure the elections. The formation of a joint commission, comprising the Malian army, rebel groups, French forces, and the United Nations Multidimensional Integrated Stabilization Mission in Mali (MINUSMA), to oversee the implementation of security measures. The inclusion of the term "Azawad" in the agreement, despite opposition from Bamako. Although the Malian government initially demanded the disarmament of the MNLA, this condition was waived in exchange for the rebels allowing the Malian army back into Kidal. Furthermore, the MNLA and HCUA did not secure an amnesty for their leaders, many of whom remained under international arrest warrants.
Other conditions that can result in similar symptoms include a hemothorax (buildup of blood in the pleural space), pulmonary embolism, and heart attack. A large bulla may look similar on a chest X-ray.
A cilium (fine hair) which projects above the surface and acts as a trigger. Spirocysts do not have cilia. A tough capsule, the cnida, which houses the thread, its payload and a mixture of chemicals that may include venom or adhesives or both. ("cnida" is derived from the Greek word κνίδη, which means "nettle") A tube-like extension of the wall of the cnida that points into the cnida, like the finger of a rubber glove pushed inwards. When a cnidocyte fires, the finger pops out. If the cell is a venomous nematocyte, the "finger"'s tip reveals a set of barbs that anchor it in the prey. The thread, which is an extension of the "finger" and coils round it until the cnidocyte fires. The thread is usually hollow and delivers chemicals from the cnida to the target. An operculum (lid) over the end of the cnida. The lid may be a single hinged flap or three flaps arranged like slices of pie. The cell body, which produces all the other parts. It is difficult to study the firing mechanisms of cnidocytes as these structures are small but very complex. At least four hypotheses have been proposed:
GamePro stated that "Gearbox has done one hell of a job in creating not just an add-on for Half-Life, but a continuation of a masterpiece", praising both level design and story elements, but noted that it was a little too short. However, some critics dissented on the idea that Opposing Force was as influential as other reviewers made out. PC Zone stated that "the taste left in the mouth is a bitter one", noting that "Opposing Force is a few excellent ideas strung together by pedestrian Half-Life padding", but concluded that "it was still a good weekend's worth of entertainment". Eurogamer stated that Opposing Force still had similar problems to other expansion packs, commenting that "X amount of new content has been created and it is going to be cut into the old content in a linear way to make it look like an all new game", but noted that "fortunately though the new stuff in Opposing Force... is pretty damn good". Although praising the level design as the game's strongest point, the reviewer felt that "towards the end of the game... they were running out of development time". Reviewing for IGN, Vincent Lopez stated that the game "does a fantastic job of making you remember exactly why you enjoyed the original so much", but criticized this as the biggest drawback, commenting that "you may find yourself wishing for a more original experience", but concluded that "for good, and bad: it's good to be back".
Sources: en.wikipedia.org
The negotiation of the Statute of Autonomy of Catalonia, which obtained a similar level of self-government ─ although the system of agreements would not be implemented there ─ and similar institutions of its own, also culminated successfully. It was submitted to referendum on the same day as that of the Basque Country, being approved with an electoral participation similar to the Basque one. Shortly thereafter, the first elections to the respective parliaments would be held, which gave victory to the PNV nationalists in the Basque Country (with Carlos Garaikoetxea as the new lehendakari) and to the Convergència nationalists in Catalonia (with Jordi Pujol as the new President of the Generalitat de Catalunya). The approval of the Basque and Catalan Statutes ─ and the discussion of the galician one ─ triggered the autonomic expectations of many regions so that the government, faced with the prospect of triggering a "carousel" of autonomic referendums, decided to "rationalize" the process. The problem arose in Andalusia, where the first steps established by article 151 had already been taken to provide itself with a Statute with the same level of self-government as the Basque and Catalan ones, so the government was forced to call the autonomic referendum recommending at the same time the abstention of the voters. The referendum was held on February 28, 1980, and the result was that the autonomic initiative was approved by the absolute majority of the registered voters, which meant a disaster for the government and for the UCD.
Some patients who have their blood pressure measured in a clinical setting have higher readings than they do when measured in a home setting. This is apparently a result of patients feeling more relaxed when they are at home. The phenomenon is sometimes called white coat hypertension, in reference to the traditional white coats worn in a clinical setting, though the coats themselves may have nothing to do with the elevated readings.
==== Travelling wave ion mobility spectrometry (TWIMS) ==== In TWIMS, ions are separated according to their mobility through a travelling wave in a gas filled cell. Both radio-frequency (RF) and direct current (DC) voltages are applied to a series of ring electrodes called a stacked ring ion guide (SRIG) to confine the ions and create a travelling wave. Based on the speed and magnitude of the travelling wave, ions can be separated. Smaller ions have higher mobility through the wave due to fewer collisions with gas molecules and exit the cell faster than ions of lower mobility (larger ions). Similar to DTIMS, CCS values of ions can be calculated with TWIMS using a calibration derived with known standards. A commercial example of the TWIMS-MS instrumentation is Waters Corp Synapt G2-S instrument.
For freezers without this feature, lowering the temperature setting to the coldest will have the same effect. Freezer Defrost: Early freezer units accumulated ice crystals around the freezing units. This was a result of humidity introduced into the units when the doors to the freezer were opened condensing on the cold parts, then freezing. This frost buildup required periodic thawing ("defrosting") of the units to maintain their efficiency. Manual Defrost (referred to as Cyclic) units are still available. Advances in automatic defrosting eliminating the thawing task were introduced in the 1950s, but are not universal, due to energy performance and cost. These units used a counter that only defrosted the freezer compartment (Freezer Chest) when a specific number of door openings had been made. The units were just a small timer combined with an electrical heater wire that heated the freezer's walls for a short amount of time to remove all traces of frost/frosting. Also, early units featured freezer compartments located within the larger refrigerator, and accessed by opening the refrigerator door, and then the smaller internal freezer door; units featuring an entirely separate freezer compartment were introduced in the early 1960s, becoming the industry standard by the middle of that decade. These older freezer compartments were the main cooling body of the refrigerator, and only maintained a temperature of around −6 °C (21 °F), which is suitable for keeping food for a week.
==== Operation Juniper Shield ==== At some point in 2013, Operation Enduring Freedom – Trans Sahara was rebadged as Operation Juniper Shield. ABC News reported that the Green Berets are also advising and assisting Niger's military to build up their fighting capability to counter the terrorist groups like al-Qaeda and ISIS. In September 2014, the Huffington post reported that members of the 19th SFG were deployed to Camp Ram Ram in Morocco as part of Operation Juniper Shield. On July 1, 2015, Army Times reported that the 3rd SFG will begin shifting its area of operations to Africa, with its focus primarily on northern and western Africa, the group expects to complete its transition out of the Middle East and Central Asia by summer 2016, as the wars in Iraq and Afghanistan wind down. Colonel Robert Wilson, the group commander, said his group "will gradually replace 10th [SFG] mission on the continent." On February 2, 2017, during a “routine administrative movement,” a Green Beret from 1st Battalion, 3rd SFG was killed and another soldier injured in a vehicle accident in Niger; according to the Stars and Stripes report Niger is a hub for special operations forces to train partner nations in north and west Africa to counter extremist groups and militants such as Boko Haram in Nigeria. On October 4, 2017, Green Berets of the 3rd SFG were ambushed. Time reported that a joint team of 12 Green Berets and 30 Nigerien troops were conducting a two-day reconnaissance mission along the Niger-Mali border.
Sources: en.wikipedia.org
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.
Laboratories typically use LC-MS/MS to detect SR9009 and related compounds in urine or blood. The method is sensitive but depends on sample collection timing. Confirmatory analysis follows quality-control procedures.
Solid material is generally kept cold, dry, and protected from light. Solutions are often stored in sealed containers at low temperature. Stability beyond recommended periods is not well documented.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.